Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...

Explore the latest advancements in Alzheimer’s drug research, revealing hope for earlier diagnosis and new treatment options.

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

This new article publication from Acta Pharmaceutica Sinica B, discusses how neg-entropy is the true drug target for chronic diseases.

Membrane proteins are vital for cellular signaling, transport, and communication, making them attractive drug targets despite their challenging properties. Advances in mass spectrometry have enabled ...

Antimicrobial resistance (AMR) is diminishing the effectiveness of existing antibiotics and intensifying the need for discovery pipelines that are both ...

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...